Water Quality in NEW PALESTINE, IN (46163)
EPA violation data for public water systems serving ZIP code 46163.
408
Total Violations
18
Health-Based
390
Monitoring / Reporting
407
Resolved
What does this mean?
407 of 408 violations have been resolved. 18 are health-based violations, meaning contaminant levels exceeded federal safety limits. The remaining 390 are monitoring or reporting violations (missed testing deadlines or late paperwork — not necessarily a water quality issue). Not all violations mean your water is unsafe. The EPA requires reporting even for minor administrative issues.
Violations Detail (408 total)
| Contaminant | Category | MCL Limit | Measured | Date | Status | Health Effects |
|---|---|---|---|---|---|---|
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 29, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 29, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 29, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 29, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 29, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 29, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2024 | Resolved | N/A |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Vinyl chloride | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Increased risk of cancer |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Barium | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Increase in blood pressure |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Barium | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Increase in blood pressure |
| Barium | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Increase in blood pressure |
| Cadmium | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Kidney damage |
| Cadmium | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Kidney damage |
| Cadmium | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Kidney damage |
| CYANIDE | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Nerve damage or thyroid problems |
| CYANIDE | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Nerve damage or thyroid problems |
| CYANIDE | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Nerve damage or thyroid problems |
| Selenium | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Carbon tetrachloride | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| Carbon tetrachloride | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| Carbon tetrachloride | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Nickel | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Nickel | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Nickel | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Thallium, Total | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Thallium, Total | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Thallium, Total | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Xylenes, Total | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Xylenes, Total | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Xylenes, Total | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Mercury | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Kidney damage |
| Mercury | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Kidney damage |
| Mercury | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Kidney damage |
| Beryllium, Total | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Chromium | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Allergic dermatitis |
| Beryllium, Total | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Beryllium, Total | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Chromium | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Allergic dermatitis |
| Chromium | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Allergic dermatitis |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Trichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| Trichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| Trichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| Antimony, Total | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Antimony, Total | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Antimony, Total | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Vinyl chloride | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Increased risk of cancer |
| Vinyl chloride | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Nov 19, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Nov 19, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Nov 19, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Nov 19, 2023 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Oct 9, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Oct 9, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Oct 9, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | May 13, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | May 13, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | May 13, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Apr 3, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Apr 3, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Apr 3, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Apr 3, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Active | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.014 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.014 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.014 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.014 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.014 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Feb 24, 2021 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Feb 24, 2021 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Feb 24, 2021 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Feb 24, 2021 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
Lead & Copper Levels
Violation Timeline
2025(8)
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Arsenic
03
Arsenic
03
Arsenic
03
Arsenic
03
2024(56)
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Arsenic
03
Arsenic
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
LEAD AND COPPER RULE REVISIONS
4G
LEAD AND COPPER RULE REVISIONS
4G
LEAD AND COPPER RULE REVISIONS
4G
LEAD AND COPPER RULE REVISIONS
2E
LEAD AND COPPER RULE REVISIONS
2E
LEAD AND COPPER RULE REVISIONS
2E
LEAD AND COPPER RULE REVISIONS
2E
LEAD AND COPPER RULE REVISIONS
2E
LEAD AND COPPER RULE REVISIONS
2E
LEAD AND COPPER RULE REVISIONS
4G
LEAD AND COPPER RULE REVISIONS
4G
LEAD AND COPPER RULE REVISIONS
4G
Arsenic
03
Arsenic
03
Arsenic
03
Arsenic
03
Revised Total Coliform Rule
3B
Revised Total Coliform Rule
3B
Revised Total Coliform Rule
3B
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Arsenic
03
Arsenic
03
Arsenic
03
Arsenic
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Arsenic
03
Arsenic
03
Arsenic
03
Arsenic
03
Arsenic
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
2023(173)
DICHLOROMETHANE
03
Vinyl chloride
03
DICHLOROMETHANE
03
Arsenic
03
Arsenic
03
Barium
03
Arsenic
03
Barium
03
Barium
03
Cadmium
03
Cadmium
03
Cadmium
03
CYANIDE
03
CYANIDE
03
CYANIDE
03
Selenium
03
Selenium
03
Selenium
03
Carbon tetrachloride
03
Carbon tetrachloride
03
Carbon tetrachloride
03
Tetrachloroethylene
03
Tetrachloroethylene
03
Tetrachloroethylene
03
Benzene
03
DICHLOROMETHANE
03
Benzene
03
Nickel
03
Nickel
03
Nickel
03
Thallium, Total
03
Thallium, Total
03
Thallium, Total
03
1,2,4-Trichlorobenzene
03
1,2,4-Trichlorobenzene
03
1,2,4-Trichlorobenzene
03
o-Dichlorobenzene
03
o-Dichlorobenzene
03
o-Dichlorobenzene
03
p-Dichlorobenzene
03
p-Dichlorobenzene
03
p-Dichlorobenzene
03
1,1-Dichloroethylene
03
1,1-Dichloroethylene
03
1,1-Dichloroethylene
03
1,2-Dichloroethane
03
1,2-Dichloroethane
03
1,2-Dichloroethane
03
1,2-Dichloropropane
03
1,2-Dichloropropane
03
1,2-Dichloropropane
03
1,1,2-Trichloroethane
03
1,1,2-Trichloroethane
03
1,1,2-Trichloroethane
03
CHLOROBENZENE
03
CHLOROBENZENE
03
CHLOROBENZENE
03
Styrene
03
Styrene
03
Styrene
03
Toluene
03
Toluene
03
Toluene
03
cis-1,2-Dichloroethylene
03
cis-1,2-Dichloroethylene
03
cis-1,2-Dichloroethylene
03
1,1,1-Trichloroethane
03
1,1,1-Trichloroethane
03
1,1,1-Trichloroethane
03
Xylenes, Total
03
Xylenes, Total
03
Xylenes, Total
03
Mercury
03
Mercury
03
Mercury
03
Beryllium, Total
03
Chromium
03
Beryllium, Total
03
Ethylbenzene
03
Ethylbenzene
03
Ethylbenzene
03
Beryllium, Total
03
Chromium
03
Chromium
03
trans-1,2-Dichloroethylene
03
trans-1,2-Dichloroethylene
03
trans-1,2-Dichloroethylene
03
Trichloroethylene
03
Trichloroethylene
03
Trichloroethylene
03
Antimony, Total
03
Antimony, Total
03
Antimony, Total
03
Vinyl chloride
03
Vinyl chloride
03
Benzene
03
Revised Total Coliform Rule
3A
Arsenic
03
Arsenic
03
Arsenic
03
Revised Total Coliform Rule
3A
Lead and Copper Rule
66
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
2A
Revised Total Coliform Rule
2A
Revised Total Coliform Rule
2A
Revised Total Coliform Rule
2A
E. COLI
34
E. COLI
34
E. COLI
34
Arsenic
03
Arsenic
03
Arsenic
03
Arsenic
03
Arsenic
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
2A
Revised Total Coliform Rule
2A
Revised Total Coliform Rule
2A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
E. COLI
34
E. COLI
34
E. COLI
34
E. COLI
34
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
2022(125)
Lead and Copper Rule
66
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Lead and Copper Rule
66
Lead and Copper Rule
66
Arsenic
02
Arsenic
02
Arsenic
02
Arsenic
02
Lead and Copper Rule
51
Lead and Copper Rule
51
Lead and Copper Rule
51
Lead and Copper Rule
51
Lead and Copper Rule
51
Lead and Copper Rule
51
Lead and Copper Rule
51
Arsenic
02
Lead and Copper Rule
51
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Arsenic
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Arsenic
03
Arsenic
03
Arsenic
03
Arsenic
03
Revised Total Coliform Rule
4B
Revised Total Coliform Rule
4B
Revised Total Coliform Rule
4B
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Lead and Copper Rule
51
Lead and Copper Rule
51
Lead and Copper Rule
51
Lead and Copper Rule
51
Lead and Copper Rule
51
Lead and Copper Rule
51
Lead and Copper Rule
51
Lead and Copper Rule
51
Arsenic
03
Arsenic
03
Arsenic
03
Arsenic
03
Arsenic
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Arsenic
03
Revised Total Coliform Rule
3A
Arsenic
03
Arsenic
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Arsenic
03
Arsenic
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
4B
Revised Total Coliform Rule
4B
Revised Total Coliform Rule
4B
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
2021(46)
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3B
Revised Total Coliform Rule
3B
Revised Total Coliform Rule
3B
Revised Total Coliform Rule
3B
Revised Total Coliform Rule
3B
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
4B
Revised Total Coliform Rule
4B
Revised Total Coliform Rule
4B
Revised Total Coliform Rule
4B
Revised Total Coliform Rule
4B
Revised Total Coliform Rule
4B
E. COLI
34
E. COLI
34
E. COLI
34
E. COLI
34
How Does This Compare?
NEW PALESTINE (46163) has 408 recorded violations, including 18 health-based. 1 remains unresolved. Consider testing your tap water independently for added peace of mind.
Recommended Water Filters
Based on the contaminants detected in your area, these filter types may help improve your water quality.
Reverse Osmosis System
Highly effective at removing heavy metals, dissolved solids, and a wide range of contaminants. Recommended for homes with lead or arsenic concerns.
Targets:Lead, Copper, Arsenic, Mercury, Cadmium
Look for:NSF/ANSI 58 certified
UV Water Purifier
Uses ultraviolet light to neutralize bacteria, viruses, and parasites without chemicals. Ideal for homes with microbial contamination concerns.
Targets:E. coli, Coliform, Giardia, Cryptosporidium
Look for:NSF/ANSI 55 (Class A) certified
Always look for filters certified by NSF International for the specific contaminants you want to remove.